Zhang X - Search Results

1

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China.

Miao K, Zhang X, Wang H, Si X, Ni J, Zhong W, Zhao J, Xu Y, Chen M, Pan R, Wang M, Zhang L. Miao K, et al. Among authors: zhang l, zhang x. Front Oncol. 2022 Mar 15;12:859938. doi: 10.3389/fonc.2022.859938. eCollection 2022. Front Oncol. 2022. PMID: 35392244 Free PMC article.

2

[Retrospective analysis of 27 cases of disseminated tuberculosis].

Zhang XT, Li LY, Zhang L, Zhu YJ, Cui QC. Zhang XT, et al. Zhonghua Nei Ke Za Zhi. 2004 Jan;43(1):41-4. Zhonghua Nei Ke Za Zhi. 2004. PMID: 14990021 Chinese.

3

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ. Mu XL, et al. BMC Cancer. 2004 Aug 19;4:51. doi: 10.1186/1471-2407-4-51. BMC Cancer. 2004. PMID: 15318946 Free PMC article. Clinical Trial.

4

[Treatment of non-small cell lung cancer with gefitinib].

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ. Zhang XT, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Mar;28(3):180-3. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854414 Chinese.

5

Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ, Song W. Zhang XT, et al. Chin Med J (Engl). 2005 Oct 5;118(19):1661-4. Chin Med J (Engl). 2005. PMID: 16232354 No abstract available.

6

Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L. Wang MZ, et al. Chin Med J (Engl). 2006 Jan 5;119(1):63-8. Chin Med J (Engl). 2006. PMID: 16454984 No abstract available.

7

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, Zhou Q, Xu CR, Wang Z, Zhang GC, Mok T. Wu YL, et al. J Thorac Oncol. 2007 May;2(5):430-9. doi: 10.1097/01.JTO.0000268677.87496.4c. J Thorac Oncol. 2007. PMID: 17473659 Free article.

8

[Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer].

Zhang L, Wang SL, Zhang XT, Li LY, Wang MZ. Zhang L, et al. Zhonghua Nei Ke Za Zhi. 2007 May;46(5):392-5. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637309 Chinese.

9

[Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].

Wu C, Li LY, Wang MZ, Zhang L, Zhang XT, Zhong W, Wang SL, Wang HZ. Wu C, et al. Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):943-5. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18478938 Clinical Trial. Chinese.

10

[Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].

Wang MZ, Zhong W, Zhang L, Li LY, Wang SL, Li JR, Zhang XT. Wang MZ, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):221-4. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756941 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,726 results

Search Page

Filters